Page last updated: 2024-08-16

ribavirin and Infections

ribavirin has been researched along with Infections in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (40.00)	29.6817
2010's	6 (60.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brass, CA; Bräu, N; Galler, GW; Lawitz, EJ; Lee, WM; Long, J; McHutchison, JG; Melia, MT; Muir, AJ; Noviello, S; Nyberg, LM; Pedicone, LD; Poordad, F; Schiff, E; Shiffman, ML; Sulkowski, MS	1
Andriulli, A; Cozzolongo, R; Fontana, R; Iacobellis, A; Ippolito, A; Minerva, N; Niro, GA; Palmieri, O; Valvano, MR	1
de Knegt, RJ; Hansen, BE; Janssen, HL; Roomer, R	1
Hodson, A; Kasliwal, M; MacMahon, E; Raj, K; Streetly, M	1
Battyáni, Z; Hunyady, B; Kovács, B	1
Kang, P; Sun, LJ; Yan, BZ; Yu, JW; Zhao, YH	1
Doo, E; Everhart, JE; Ghany, MG; Heller, T; Hoofnagle, JH; Liang, TJ; Park, Y; Promrat, K; Soza, A	1
Antonini, MG; Babudieri, S; Baiguera, C; Carosi, G; Fenu, L; Maida, I; Mura, MS; Puoti, M; Putzolu, V; Rezza, G; Rossi, S; Sassu, S; Viale, P; Zanini, B	1
Barrios Peinado, C; Boullosa Graña, E; Cuervas-Mons Martinez, V; Garrido Botella, A; Jiménez Garrido, M; Lucena Poza, JL; Moreno Planas, JM; Rubio Gonzalez, E; Sanchez Turrion, V	1
Antonini, MG; Babudieri, S; Baiguera, C; Carosi, G; Dettori, G; Fenu, L; Maida, I; Manno, D; Mura, MS; Puoti, M; Zanini, B	1

Reviews

1 review(s) available for ribavirin and Infections

Article	Year
[Side-effects of pegylated interferon plus ribavirin therapy with or without protease inhibitor direct acting antiviral agents during treatment of chronic hepatitis C virus infection]. Orvosi hetilap, 2011, Dec-11, Volume: 152, Issue:50 Topics: Affect; Anemia, Hypochromic; Antiviral Agents; Autoimmune Diseases; Autoimmunity; Cardiovascular System; Clinical Trials as Topic; Drug Eruptions; Drug Synergism; Drug Therapy, Combination; Endocrine System Diseases; Eye; Hepatitis C, Chronic; Humans; Infections; Interferon alpha-2; Interferon-alpha; Neutropenia; Oligopeptides; Polyethylene Glycols; Proline; Protease Inhibitors; Recombinant Proteins; Respiratory System; Ribavirin; Risk Factors; Thrombocytopenia	2011

Article

Year

[Side-effects of pegylated interferon plus ribavirin therapy with or without protease inhibitor direct acting antiviral agents during treatment of chronic hepatitis C virus infection].

Orvosi hetilap, 2011, Dec-11, Volume: 152, Issue:50

Topics: Affect; Anemia, Hypochromic; Antiviral Agents; Autoimmune Diseases; Autoimmunity; Cardiovascular System; Clinical Trials as Topic; Drug Eruptions; Drug Synergism; Drug Therapy, Combination; Endocrine System Diseases; Eye; Hepatitis C, Chronic; Humans; Infections; Interferon alpha-2; Interferon-alpha; Neutropenia; Oligopeptides; Polyethylene Glycols; Proline; Protease Inhibitors; Recombinant Proteins; Respiratory System; Ribavirin; Risk Factors; Thrombocytopenia

2011

Trials

2 trial(s) available for ribavirin and Infections

Article	Year
Infections during peginterferon/ribavirin therapy are associated with the magnitude of decline in absolute lymphocyte count: results of the IDEAL study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Volume: 58, Issue:7 Topics: Adolescent; Adult; Aged; Female; Hepatitis C; Humans; Incidence; Infections; Interferon alpha-2; Interferon-alpha; Lymphocyte Count; Lymphopenia; Male; Middle Aged; Multivariate Analysis; Neutrophils; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Assessment; Risk Factors; Young Adult	2014
Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin. Infection, 2008, Volume: 36, Issue:3 Topics: Adolescent; Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Incidence; Infections; Interferon alpha-2; Interferon-alpha; Leukocyte Count; Male; Middle Aged; Neutropenia; Neutrophils; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome	2008

Article

Year

Infections during peginterferon/ribavirin therapy are associated with the magnitude of decline in absolute lymphocyte count: results of the IDEAL study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Volume: 58, Issue:7

Topics: Adolescent; Adult; Aged; Female; Hepatitis C; Humans; Incidence; Infections; Interferon alpha-2; Interferon-alpha; Lymphocyte Count; Lymphopenia; Male; Middle Aged; Multivariate Analysis; Neutrophils; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Assessment; Risk Factors; Young Adult

2014

Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin.

Infection, 2008, Volume: 36, Issue:3

Topics: Adolescent; Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Incidence; Infections; Interferon alpha-2; Interferon-alpha; Leukocyte Count; Male; Middle Aged; Neutropenia; Neutrophils; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome

2008

Other Studies

7 other study(ies) available for ribavirin and Infections

Article	Year
Feasibility of pegylated interferon and ribavirin in hepatitis C-related cirrhosis with neutropenia or thrombocytopenia. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2014, Volume: 46, Issue:7 Topics: Aged; Antiviral Agents; Drug Therapy, Combination; Epistaxis; Esophageal and Gastric Varices; Feasibility Studies; Female; Gastrointestinal Hemorrhage; Gingival Hemorrhage; Hepatitis C, Chronic; Humans; Infections; Interferon-alpha; Leukocyte Count; Liver Cirrhosis; Male; Middle Aged; Neutropenia; Neutrophils; Platelet Count; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Thrombocytopenia	2014
Risk factors for infection during treatment with peginterferon alfa and ribavirin for chronic hepatitis C. Hepatology (Baltimore, Md.), 2010, Volume: 52, Issue:4 Topics: Adolescent; Adult; Aged; Antiviral Agents; Bacterial Infections; Cohort Studies; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Infections; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors	2010
A parainfluenza-3 outbreak in a SCT unit: sepsis with multi-organ failure and multiple co-pathogens are associated with increased mortality. Bone marrow transplantation, 2011, Volume: 46, Issue:12 Topics: Adult; Aged; Anti-Bacterial Agents; Antiviral Agents; Disease Outbreaks; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infection Control; Infections; Lung Diseases; Male; Middle Aged; Multiple Organ Failure; Parainfluenza Virus 3, Human; Respirovirus Infections; Ribavirin; Sepsis; Survival Rate; Transplantation, Autologous; Transplantation, Homologous	2011
[A study of the relationship between neutropenia and clinical infection risk during treatment with peginterferon alfa-2a and ribavirin for chronic hepatitis C]. Zhonghua nei ke za zhi, 2012, Volume: 51, Issue:1 Topics: Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Hepatitis C, Chronic; Humans; Infections; Interferon-alpha; Leukocyte Count; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors	2012
Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C. Hepatology (Baltimore, Md.), 2002, Volume: 36, Issue:5 Topics: Adult; Antiviral Agents; Black People; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Infections; Interferon-alpha; Leukocyte Count; Male; Middle Aged; Neutropenia; Neutrophils; Prevalence; Retrospective Studies; Ribavirin; United States; White People	2002
Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation? Antiviral therapy, 2004, Volume: 9, Issue:4 Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Infections; Interferon alpha-2; Interferon Type I; Interferon-alpha; Italy; Longitudinal Studies; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Proportional Hazards Models; Recombinant Proteins; Respiratory Tract Infections; Retrospective Studies; Ribavirin	2004
Peginterferon and ribavirin in patients with HCV cirrhosis after liver transplantation. Transplantation proceedings, 2005, Volume: 37, Issue:5 Topics: Adult; Aged; Antiviral Agents; Female; Hepatitis C; Humans; Immunosuppressive Agents; Infections; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin; Viral Load	2005